Search Results - "Remitz, A."

Factors associated with severity of atopic dermatitis – a Finnish cross‐sectional study by Salava, A., Salo, V., Leppänen, J., Lauerma, A., Remitz, A.

“…Background Severity‐associated factors in atopic dermatitis (AD) have focussed on early onset, concomitant atopic diseases, markers of Th2‐shifted inflammation…”
Get full text

Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study by Salava, A., Perälä, M., Pelkonen, A., Mäkelä, M., Remitz, A.

“…Summary Background Topical tacrolimus is used off‐label in young children, but data are limited on its use in children under 2 years of age and for long‐term…”
Get full text

The spectrum of skin‐related conditions in primary care during 2015–2019–A Finnish nationwide database study by Salava, A., Oker‐Blom, A., Remitz, A.

“…Summary Background Skin‐related conditions are the frequent cause of doctors’ consultations in primary care. Methods Based on nationwide data bank information…”
Get full text

Position statement: topical calcineurin inhibitors in atopic dermatitis by Remitz, A., De Pità, O., Mota, A., Serra‐Baldrich, E., Vakirlis, E., Kapp, A.

“…Background Atopic dermatitis (AD) is a common inflammatory skin disease in both adults and children. Whilst topical calcineurin inhibitors (TCIs), tacrolimus…”
Get full text

High serum total IgE predicts poor long-term outcome in atopic dermatitis by Kiiski, Ville, Karlsson, Oskar, Remitz, Anita, Reitamo, Sakari

“…Most patients with severe atopic dermatitis have elevated serum IgE levels, but there has been little research into IgE as a predictive biomarker in long-term…”
Get full text

Hit early and hit hard in atopic dermatitis and not only in asthma by Reitamo, S, Remitz, A, Haahtela, T

Get full text

Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment by Doss, N., Kamoun, M.-R., Dubertret, L., Cambazard, F., Remitz, A., Lahfa, M., De Prost, Y.

“…Doss N, Kamoun M‐R, Dubertret L, Cambazard F, Remitz A, Lahfa M, de Prost Y. Efficacy of tacrolimus 0.03% ointment as second‐line treatment for children with…”
Get full text

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis by Kyllönen, H., Remitz, A., Mandelin, J.M., Elg, P., Reitamo, S.

“…Summary Background  Topical corticosteroids decrease collagen synthesis during short‐term treatment and can induce skin atrophy when applied over the long…”
Get full text

Paradoxical rise in serum adiponectin concentration in the face of 13-cis-retinoic acid-induced insulin resistance by KOISTINEN, H. A, REMITZ, A, KOIVISTO, V. A, EBELING, P

Get full text

Tacrolimus ointment improves psoriasis in a microplaque assay by REMITZ, A, REITAMO, S, ERKKO, P, GRANLUND, H, LAUERMA, A. I

“…Tacrolimus (FK506) is an effective and well tolerated immunosuppressant used to prevent allograft rejection. We describe the evaluation of two tacrolimus…”
Get full text

Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients by Eklund, K K, Remitz, A, Kautiainen, H, Reitamo, S, Leirisalo-Repo, M

Get full text

Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic by Koistinen, H. A, Remitz, A, Koivisto, V. A, Ebeling, P

“…Aims/hypothesis We previously reported that treatment of acne with 13-cis-retinoic acid causes insulin resistance and disturbances in lipid metabolism…”
Get full text

Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis by Kyllönen, H., Malmberg, P., Remitz, A., Rytilä, P., Metso, T., Helenius, I., Haahtela, T., Reitamo, S.

“…Summary Background Patients with atopic dermatitis (AD) often have symptoms suggestive of asthma or rhinitis. The prevalence and signs of respiratory disease…”
Get full text

Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis by ERKKO, P, GRANLUND, H, REMITZ, A, ROSEN, K, MOBACKEN, H, LINDELÖF, B, REITAMO, S

“…We previously showed in a double‐blind, placebo‐controlled study that cyclosporin at a dose of 2.5 mg/kg per day is an effective treatment for palmoplantar…”
Get full text

Treatment of lichenified atopic eczema with tacrolimus ointment by Granlund, H, Remitz, A, Kyllönen, H, Lauerma, A I, Reitamo, S

Get full text

Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcriptional level by Reitamo, S, Remitz, A, Tamai, K, Ledo, I, Uitto, J

“…In immune cells, such as T cells and monocytes, interleukin 10 (IL-10) has regulatory functions on a number of cytokines, including IL-1, IL-2, IL-8 and tumour…”
Get full text

Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol) by Remitz, A

“…Previous studies have shown that when butantrone and dithranol were used in equimolar gradually increasing concentrations in short-contact therapy for…”
Get more information

Are Infants and Toddlers with Moderate-to-severe Atopic Dermatitis Undertreated? Experiences of a Finnish Tertiary Care Hospital by Antti, Andreas, Salava, Alexander, Perälä, Miia, Pelkonen, Anna S, Mäkelä, Mika J, Remitz, Anita

Get full text

The Value of FLG Null Mutations in Predicting Treatment Response in Atopic Dermatitis: An Observational Study in Finnish Patients by Luukkonen, Tiia Maria, Kiiski, Ville, Ahola, Maria, Mandelin, Johanna, Virtanen, Hannele, Pöyhönen, Minna, Kivirikko, Sirpa, Surakka, Ida, Reitamo, Sakari, Palotie, Aarno, Heliövaara, Markku, Jakkula, Eveliina, Remitz, Anita

“…The contribution of filaggrin null mutations to predicting atopic dermatitis (AD) treatment response is not clear, nor have such mutations been studied in the…”
Get full text

Clinical Management of Atopic Dermatitis in Adults: Mapping of Expert Opinion in 4 Nordic Countries using a Modified Delphi Process by Thyssen, Jacob P, Berents, Teresa, Bradley, Maria, Deleuran, Mette, Grimstad, Øystein, Korhonen, Laura, Langeland, Tor, Särnhult, Tore, Thomsen, Simon Francis, Thune, Turid, Wahlgren, Carl-Fredrik, Vestergaard, Christian, Kobyletzki, Laura B, Remitz, Anita

“…Similarities and differences in the everyday clinical management of moderate-to-severe atopic dermatitis in Nordic countries are unknown. Using a modified…”
Get full text